Think Twice Before Prescribing DPP-4 Inhibitors for DiabetesThink Twice Before Prescribing DPP-4 Inhibitors for Diabetes

In this commentary, the author raises thought-provoking questions regarding the potential risks and benefits of using sitagliptin in high-risk patients with inadequately controlled type 2 diabetes. Evidence-Based Medicine
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news